BioAge Labs Inc. Share Price Today: Live Updates & Key Insights

BioAge Labs Inc. share price today is $19.39, up -8.27%. The stock opened at $20.73 against the previous close of $21.04, with an intraday high of $20.73 and low of $18.77.

BioAge Labs Inc. Share Price Chart

BioAge Labs Inc.

us-stock
To Invest in {{usstockname}}
us-stock

BioAge Labs Inc. Share Price Performance

$19.39 -0.0827(-8.27%) BIOA at 23 Mar 2026 12:13 PM Drug Manufacturers - Specialty & Generic
Lowest Today 18.77
Highest Today 20.73
Today’s Open 20.73
Prev. Close 21.04
52 Week High 24.00
52 Week Low 2.88
Day’s Range: Low 18.77 High 20.73
52-Week Range: Low 2.88 High 24.00
1 day return -
1 Week return -10.8
1 month return -9.84
3 month return +41.47
6 month return +277.25
1 year return +325.19
3 year return -
5 year return -
10 year return -

BioAge Labs Inc. Institutional Holdings

BioAge Labs Inc. Market Status

Strong Buy: 0

Buy: 0

Hold: 3

Sell: 0

Strong Sell: 1

BioAge Labs Inc. Fundamentals

Market Cap 805.82 M

PB Ratio 3.1616

PE Ratio 1.4181

Enterprise Value 599.83 M

Total Assets 358.23 M

Volume 1935716

BioAge Labs Inc. Company Financials

About BioAge Labs Inc. & investment objective

Company Information BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Organisation Drug Manufacturers - Specialty & Generic

Employees 62

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Kristen Fortney Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioAge Labs Inc. FAQs

What is the share price of BioAge Labs Inc. today?

The current share price of BioAge Labs Inc. is $19.39.

Can I buy BioAge Labs Inc. shares in India?

Yes, Indian investors can buy BioAge Labs Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioAge Labs Inc. shares in India?

You can easily invest in BioAge Labs Inc. shares from India by:

Can I buy fractional shares of BioAge Labs Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioAge Labs Inc.?

BioAge Labs Inc. has a market cap of $805.82 M.

In which sector does BioAge Labs Inc. belong?

BioAge Labs Inc. operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in BioAge Labs Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of BioAge Labs Inc.?

The PE ratio of BioAge Labs Inc. is 1.42 and the PB ratio is 3.16.